combination_therapy_in_asthma__COPD重点分析.ppt

* * ODonnell DE, Sciurba F, Celli B, et al. Effect of fluticasone propionate/salmeterol on lung hyperinflation and exercise endurance in COPD. Chest 2006; 130: 647-56. * * SFC statistically significantly better than placebo at 6-months (p=0.001) Adjusted mean change at 3 years SFC= -1.2, FP = -0.2, Sal = 1, Plac = 2.1 Therefore Steroid containing groups prevented expected decline over 3 years I want to build this slide starting with placebo, then salmeterol, then FP then SFC Also put in line for zero Move legend to upper right arranged vertically building with the plots Haven’t yet formed a